• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人 cherubism 的分子和细胞特征:疾病侵袭性取决于破骨细胞分化。

Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

机构信息

INSERM, UMRS 1138 Equipe 5, Laboratoire de Physiopathologie Orale Moléculaire, Centre de Recherche de Cordeliers, 75006, Paris, France.

Université Paris Descartes, 75006, Paris, France.

出版信息

Orphanet J Rare Dis. 2018 Sep 20;13(1):166. doi: 10.1186/s13023-018-0907-2.

DOI:10.1186/s13023-018-0907-2
PMID:30236129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6148781/
Abstract

BACKGROUND

Cherubism is a rare autosomal dominant disorder of the jaws caused by mutation of the SH3BP2 gene. The bone is replaced by a fibrous granuloma containing multinucleated giant cells. Cells of the cherubism granuloma have never been systematically analyzed. Hence, the aim of this study was to characterize the cells in human cherubism granulomas, to determine the osteoclastic characteristics of the multinucleated giant cells and to investigate the potential role of TNF-α in human cherubism.

RESULTS

Seven granulomas were analyzed in pathology, molecular biology and immunohistochemistry. Granulomas were composed mainly of macrophages or osteoclasts within a fibroblastic tissue, with few lymphoid cells. Myeloid differentiation and nuclear NFATc1 localization were both associated with disease aggressiveness. OPG and RANKL immunohistochemical expression was unexpected in our specimens. Five granuloma cells were cultured in standard and osteoclastogenic media. In culture, cherubism cells were able to differentiate into active osteoclasts, in both osteoclastogenic and standard media. IL-6 was the major cytokine present in the culture supernatants.

CONCLUSION

Multinucleated giant cells from cherubism granulomas are CD68 positive cells, which differentiate into macrophages in non-aggressive cherubism and into osteoclasts in aggressive cherubism, stimulated by the NFATc1 pathway. This latter differentiation appears to involve a disturbed RANK-L/RANK/OPG pathway and be less TNF-α dependent than the cherubism mouse model.

摘要

背景

cherubism 是一种罕见的常染色体显性遗传颌骨疾病,由 SH3BP2 基因突变引起。骨骼被纤维性肉芽肿取代,其中包含多核巨细胞。 cherubism 肉芽肿中的细胞从未被系统地分析过。因此,本研究的目的是分析人 cherubism 肉芽肿中的细胞,确定多核巨细胞的破骨细胞特征,并研究 TNF-α 在人 cherubism 中的潜在作用。

结果

在病理学、分子生物学和免疫组织化学方面分析了 7 个肉芽肿。肉芽肿主要由成纤维组织中的巨噬细胞或破骨细胞组成,淋巴细胞较少。髓样分化和核 NFATc1 定位都与疾病的侵袭性有关。在我们的标本中,OPG 和 RANKL 的免疫组织化学表达出乎意料。将 5 个肉芽肿细胞在标准和破骨细胞生成培养基中培养。在培养中, cherubism 细胞能够在破骨细胞生成和标准培养基中分化为活性破骨细胞。IL-6 是培养上清液中主要的细胞因子。

结论

cherubism 肉芽肿中的多核巨细胞是 CD68 阳性细胞,在非侵袭性 cherubism 中分化为巨噬细胞,在侵袭性 cherubism 中分化为破骨细胞,受 NFATc1 途径的刺激。这种分化似乎涉及到 RANK-L/RANK/OPG 途径的紊乱,并且比 cherubism 小鼠模型更不依赖 TNF-α。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/ec4dd6fffaf3/13023_2018_907_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/8b5b083db269/13023_2018_907_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/42266aa5c566/13023_2018_907_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/ad876571415e/13023_2018_907_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/7639fcb50481/13023_2018_907_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/6b19d930796c/13023_2018_907_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/ec4dd6fffaf3/13023_2018_907_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/8b5b083db269/13023_2018_907_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/42266aa5c566/13023_2018_907_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/ad876571415e/13023_2018_907_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/7639fcb50481/13023_2018_907_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/6b19d930796c/13023_2018_907_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/6148781/ec4dd6fffaf3/13023_2018_907_Fig6_HTML.jpg

相似文献

1
Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.人 cherubism 的分子和细胞特征:疾病侵袭性取决于破骨细胞分化。
Orphanet J Rare Dis. 2018 Sep 20;13(1):166. doi: 10.1186/s13023-018-0907-2.
2
SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.SH3BP2 cherubism 突变通过NFATc1和TNF-α介导的炎症性骨质流失增强TNF-α诱导的破骨细胞生成。
J Bone Miner Res. 2014 Dec;29(12):2618-35. doi: 10.1002/jbmr.2295.
3
Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.定义一种新的侵袭性分类,并将NFATc1定位作为颌骨肥大症的预后因素。
Hum Pathol. 2016 Dec;58:62-71. doi: 10.1016/j.humpath.2016.07.019. Epub 2016 Aug 3.
4
Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.在颌骨各种含巨细胞性病变中出现的多核巨细胞表现出破骨细胞的特征。
J Oral Pathol Med. 2003 Jul;32(6):367-75. doi: 10.1034/j.1600-0714.2003.00126.x.
5
NFATc1 and TNFalpha expression in giant cell lesions of the jaws.NFATc1 和 TNFalpha 在颌骨巨细胞病变中的表达。
J Oral Pathol Med. 2010 Mar;39(3):269-74. doi: 10.1111/j.1600-0714.2009.00855.x. Epub 2009 Dec 11.
6
The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism.钙调神经磷酸酶抑制剂他克莫司作为重型颌骨肥大症的一种新疗法。
J Bone Miner Res. 2015 May;30(5):878-85. doi: 10.1002/jbmr.2431.
7
SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.在除 cherubism 外的巨细胞病变中,SH3BP2 在第9外显子中很少发生突变。
Clin Orthop Relat Res. 2007 Jun;459:22-7. doi: 10.1097/BLO.0b013e31804b4131.
8
Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.通过降低 TGFβ 信号转导挽救 cherubism 骨髓基质细胞培养表型。
Bone. 2018 Jun;111:28-35. doi: 10.1016/j.bone.2018.03.009. Epub 2018 Mar 9.
9
Jawing about TNF: new hope for cherubism.聊聊肿瘤坏死因子:小儿颌骨肥大症的新希望。
Cell. 2007 Jan 12;128(1):15-7. doi: 10.1016/j.cell.2006.12.019.
10
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.小鼠中的NFATc1在破骨细胞生成过程中抑制骨保护素,并在 cherubism 中将全身性骨质减少与炎症分离。
J Clin Invest. 2008 Nov;118(11):3775-89. doi: 10.1172/JCI35711. Epub 2008 Oct 9.

引用本文的文献

1
Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer.转录因子的综合分析确定了人类膀胱癌中的新型预后生物标志物。
J Cancer. 2021 Jul 25;12(18):5605-5621. doi: 10.7150/jca.58484. eCollection 2021.
2
Cherubism with orbital involvement.伴有眼眶受累的颌骨多囊性纤维性骨营养不良
Indian J Ophthalmol. 2020 Nov;68(11):2534. doi: 10.4103/ijo.IJO_870_20.
3
Cherubism as a systemic skeletal disease: evidence from an aggressive case.颌骨肥大症作为一种全身性骨骼疾病:来自一例侵袭性病例的证据。

本文引用的文献

1
Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.定义一种新的侵袭性分类,并将NFATc1定位作为颌骨肥大症的预后因素。
Hum Pathol. 2016 Dec;58:62-71. doi: 10.1016/j.humpath.2016.07.019. Epub 2016 Aug 3.
2
RANKL/OPG; Critical role in bone physiology.核因子κB受体活化因子配体/骨保护素;在骨生理学中起关键作用。
Rev Endocr Metab Disord. 2015 Jun;16(2):131-9. doi: 10.1007/s11154-014-9308-6.
3
The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism.钙调神经磷酸酶抑制剂他克莫司作为重型颌骨肥大症的一种新疗法。
BMC Musculoskelet Disord. 2020 Aug 21;21(1):564. doi: 10.1186/s12891-020-03580-z.
4
A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.罕见骨病骨活检评估中先进技术的临床视角。
Front Endocrinol (Lausanne). 2020 Jun 23;11:399. doi: 10.3389/fendo.2020.00399. eCollection 2020.
5
Investigating global gene expression changes in a murine model of cherubism.研究 cherubism 小鼠模型中的全球基因表达变化。
Bone. 2020 Jun;135:115315. doi: 10.1016/j.bone.2020.115315. Epub 2020 Mar 10.
6
Molecular findings in maxillofacial bone tumours and its diagnostic value.颌面骨肿瘤的分子研究及其诊断价值。
Virchows Arch. 2020 Jan;476(1):159-174. doi: 10.1007/s00428-019-02726-2. Epub 2019 Dec 14.
J Bone Miner Res. 2015 May;30(5):878-85. doi: 10.1002/jbmr.2431.
4
Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism.增强的TLR-MYD88信号传导刺激SH3BP2 cherubism小鼠的自身炎症反应并确定cherubism的病因。
Cell Rep. 2014 Sep 25;8(6):1752-1766. doi: 10.1016/j.celrep.2014.08.023. Epub 2014 Sep 15.
5
SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.SH3BP2 cherubism 突变通过NFATc1和TNF-α介导的炎症性骨质流失增强TNF-α诱导的破骨细胞生成。
J Bone Miner Res. 2014 Dec;29(12):2618-35. doi: 10.1002/jbmr.2295.
6
Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology.常染色体显性遗传骨硬化症 II 型破骨细胞中差异表达的基因揭示了破骨细胞生物学的已知和新途径。
Lab Invest. 2014 Mar;94(3):275-85. doi: 10.1038/labinvest.2013.140. Epub 2013 Dec 16.
7
Autoinflammatory bone diseases.自身炎症性骨病。
Rheum Dis Clin North Am. 2013 Nov;39(4):735-49. doi: 10.1016/j.rdc.2013.05.002. Epub 2013 Aug 17.
8
Autoinflammatory bone disorders.自身炎症性骨病。
Clin Immunol. 2013 Jun;147(3):185-96. doi: 10.1016/j.clim.2012.12.012. Epub 2013 Jan 5.
9
Nocturnal mouthpiece ventilation and medical hypnosis to treat severe obstructive sleep apnea in a child with cherubism.夜间口部通气和医疗催眠治疗 cherubism 患儿重度阻塞性睡眠呼吸暂停。
Pediatr Pulmonol. 2013 Sep;48(9):927-9. doi: 10.1002/ppul.22686. Epub 2012 Nov 5.
10
Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children. cherubism 中的抗肿瘤坏死因子治疗——两例儿童的临床、放射学和组织学发现。
Bone. 2013 Jan;52(1):347-53. doi: 10.1016/j.bone.2012.10.003. Epub 2012 Oct 12.